Ritter Daniher Financial Advisory’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.67K Hold
325
﹤0.01% 487
2026
Q1
$7.16K Hold
325
﹤0.01% 472
2025
Q4
$3.83K Hold
325
﹤0.01% 528
2025
Q3
$5.15K Hold
325
﹤0.01% 394
2025
Q2
$3.72K Hold
325
﹤0.01% 295
2025
Q1
$4.4K Hold
325
﹤0.01% 272
2024
Q4
$5.49K Hold
325
﹤0.01% 260
2024
Q3
$6.6K Hold
325
﹤0.01% 257
2024
Q2
$7.34K Hold
325
﹤0.01% 245
2024
Q1
$8.54K Hold
325
﹤0.01% 228
2023
Q4
$10.3K Sell
325
-20
-6% -$543 ﹤0.01% 227
2023
Q3
$9.68K Hold
345
﹤0.01% 231
2023
Q2
$12.7K Buy
345
+20
+6% +$610 0.01% 201
2023
Q1
$9.73K Hold
325
﹤0.01% 210
2022
Q4
$9.95K Sell
325
-21
-6% -$630 ﹤0.01% 205
2022
Q3
$9K Hold
346
0.01% 179
2022
Q2
$11K Hold
346
0.01% 161
2022
Q1
$11K Hold
346
0.01% 164
2021
Q4
$12K Hold
346
0.01% 149
2021
Q3
$10K Hold
346
0.01% 157
2021
Q2
$12K Buy
+346
New +$11.5K 0.01% 147

Other funds holding CC

Ritter Daniher Financial Advisory's CC Position: Q2 2026 in Review

Ritter Daniher Financial Advisory held its Chemours (CC) position steady in Q2 2026 at 325 shares worth $6.67K. The position accounts for ﹤0.01% of the portfolio, ranked #487.

Ritter Daniher Financial Advisory first reported a position in CC in Q2 2021 and has held it in 21 quarters since. The position peaked at $12.7K in Q2 2023. 470 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Ritter Daniher Financial Advisory held 325 shares of Chemours worth $6.67K as of Q2 2026.
  • Ritter Daniher Financial Advisory left its Chemours share count unchanged in Q2 2026.
  • Chemours made up ﹤0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #487 holding.
  • Ritter Daniher Financial Advisory first reported a position in Chemours in Q2 2021 and has held it in 21 quarters since.
  • Ritter Daniher Financial Advisory's Chemours position peaked at $12.7K in Q2 2023.
  • 470 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.